EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS076-00087 
Organism
Homo sapiens 
Tissue/cell
H1 
Coordinate
chr1:1589860-1591890 
TF binding sites/motifs
Number: 3             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
KLF13MA0657.1chr1:1590682-1590700GAGCGACGCCCACTTTTG+6.07
NRF1MA0506.1chr1:1590709-1590720GCGCCTGCGCG+6.14
RESTMA0138.2chr1:1590042-1590063ACTAGCACACTGGACAGCTGC+6.14
Number of super-enhancer constituents: 34             
IDCoordinateTissue/cell
SE_00825chr1:1589838-1590395Adipose_Tissue
SE_00825chr1:1590689-1591113Adipose_Tissue
SE_11139chr1:1587919-1596820CD20
SE_12366chr1:1589389-1591832CD3
SE_12593chr1:1589947-1590378CD34_adult
SE_12593chr1:1590715-1591055CD34_adult
SE_12811chr1:1589948-1590311CD34_fetal
SE_12811chr1:1590642-1591077CD34_fetal
SE_14478chr1:1588394-1591810CD4_Memory_Primary_7pool
SE_15645chr1:1589110-1591751CD4_Memory_Primary_8pool
SE_16023chr1:1589249-1591934CD4_Naive_Primary_7pool
SE_16832chr1:1589180-1591948CD4_Naive_Primary_8pool
SE_17401chr1:1588041-1592240CD4p_CD25-_CD45RAp_Naive
SE_17899chr1:1588463-1592210CD4p_CD25-_CD45ROp_Memory
SE_18811chr1:1588147-1592096CD4p_CD25-_Il17-_PMAstim_Th
SE_19243chr1:1588621-1591862CD4p_CD25-_Il17p_PMAstim_Th17
SE_20145chr1:1588901-1591846CD56
SE_21280chr1:1588933-1591845CD8_Memory_7pool
SE_21791chr1:1588700-1591708CD8_Naive_7pool
SE_22403chr1:1588488-1591849CD8_primiary
SE_23152chr1:1588901-1591692Colon_Crypt_1
SE_23805chr1:1589499-1591176Colon_Crypt_2
SE_23805chr1:1591249-1591536Colon_Crypt_2
SE_24735chr1:1588929-1591710Colon_Crypt_3
SE_30177chr1:1589486-1592165Fetal_Muscle
SE_40542chr1:1588824-1591801K562
SE_41278chr1:1589360-1592092Left_Ventricle
SE_45139chr1:1589217-1591859NHLF
SE_47952chr1:1589497-1591211Pancreas
SE_47952chr1:1591251-1591544Pancreas
SE_50179chr1:1588928-1591702Sigmoid_Colon
SE_52422chr1:1588805-1591767Small_Intestine
SE_53355chr1:1588883-1591945Spleen
SE_65325chr1:1588568-1592205Pancreatic_islets
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr115908001591600
Enhancer Sequence
GGTAACGTAA TTCACCTCAG TTTAGTCTTC CGTACAACCA GAATAACAAC ACCTACGTGA 60
TAGTATCGAT CGCGGATTAA AGATCATCCG TTTAAAGGCT CTTAACTCAG GACCTGCCAC 120
TCATCAAACA CTGCTTTTAC TGTCAGAATC TGCTAGAAAG ACCGCTTGGA CTACGTGAAG 180
CCACTAGCAC ACTGGACAGC TGCACCTTGA GACCGGGGAG ATGCTCCGAG ATGTGCTCGC 240
GAACAAGGCC ACCTGACCCG GGCACTGGGC TATTTCCTCG GGTTCAGTCC CGCACACTTG 300
AGGTTCAGCC TGGCAGACGT TGGCTCCAGA CAGCGTTTGG ACCCGCCGCC TCCACCACCC 360
AAAGTTCCGT GCGGGATGAG ACTGTCCGCG GAAGCGAGGG TGTCGCTCGC CCCCGGGCCC 420
GGGTCCGCCC CGCTCCGAGG CCTGCTCGGA AGAAAGACCT CGGTGCACAG TTCTCCTCGC 480
GCTCCCACAC CTGGTCCGCC CAGTCGGAAC TCACCCCTAC GCCGCCGCCG CTGCCGCCGC 540
CGCCGCCGCC GGTCCCGGAG CCAGAGAAGA AACAGCAACC GGCGCGCGCC AAAAGTATCG 600
TCACTTCCTG TATTGGCGCG TAATGATGAT ATAATAGCCG ACCTCCGGCC CAGAACTCGA 660
GACAAGGACA GGGGCTCGCT CTGTGCGGCA CTTCCTGTGT CTGCGCGGGA TGATGACGCA 720
TAAAACAGCG CTTGCTCAGG TCCAGGACGC CAGAAGAAAC AGCCCGGTGA GCGCACTTCC 780
GACTTCGGCG CGGGCTGTGA CGCAGGAATC GGGACTCCGG GGGAGCGACG CCCACTTTTG 840
GAGCAGTTTG CGCCTGCGCG GAACGCGTGG CCGGCTTCCG GAATCCTACC GGGACTTTTC 900
CGGTAGCGAA GCCCGCGCCT GTGCCAAGGC TTGCGAGCAG AATGCCTTCG CGATGGACGC 960
CCGCATTCCA CCCCCTTGAC CGCTGGGACC CCTAGTGGCG GGTGGGTGGA GCGCGCTCCA 1020
TTTACCTGCT GGTTACCTCG TGAGGCGCCT CAGGTCTGTG TGTCTTGTAA AGGCCGATCT 1080
CGGAATTTAA CTCTGAACCT TACTCAGAAA CAGGGCAGGG AGAGCTCTTA CGATGTGATT 1140
TTATTTTATT TATTCATGTA TTTACTTTTG AGTCGGAGCC TTGCTCTGCC GCCCAGGTTG 1200
GAGTGCAGTG GCGTGGTCTT GGCTCACTGC AGCCTCCTCC CGGGTTCAAG GAATTTTCCT 1260
GCCTCAGCCT CCCGAGTAGC TGGAACCACA GGCCCGCGCC ACCACGCCCG GCTAATTTTT 1320
ATATTTTTGG TAGAGACGAG GTTTCGCCAT ATTGGCCAGG CTGGTCTCGA ACTCCTGACC 1380
TCAAGTGATC CGCCCGCTTC GTCCTCCTAA AGTGCTGGGA TTACAGGCGT GAGCCACCGC 1440
GCCCGGCCTT TTACAATGTG ATTTTGAAGC TGACACTGGC AGTGGGTCCT CAAAGTGCAG 1500
ACTCACTGGG TATGGTGCTT CCCCCAACTC CCAGGGCCCC ACTCCAAACC CATGGATTCA 1560
GAGCATTGCA GGAGAAGAGG ATAAAACGAG CAATTAATTC CCTTTCCATA TGTCAGGTTT 1620
TCCTCTTGAC TTGAAAAGTC ACAGAAAAAT GCTTTAGACA TCTGAATCTC AGGAAACAAA 1680
CAATGGAAGA TAAACATCCG CATTTACTGG GCCTGAAATG GGAAAATGAA AGATGTGGCA 1740
AGAAACTGAC AAGGGCCCAA GAAGGGCGAT GGGTATCGGA ATTTTTTTCA TCCCGGAATG 1800
AAATGCTGCT TGCTTTGTGT ACCCAAGCTC TTTTTTTATT TTTATTTTTT TGAGACGGAG 1860
TCTCGCTCTG TTGCCCAGGC TGGAGTGCAG TGGCGCGATC TCGGGTCACT GGAAGCTCCG 1920
CCACCCGGAT TCACGCCATT CTCCCGCCTC CACTCCATTC GCCCGCATTA GGCTCCTGAG 1980
TACCTGTGAC TACAGGCGCC TGCCACCACG CCCGGCTAAT TTTTTTTTTA 2030